Viewing nowCresban Tablet 10mg (Rosuvastatin Calcium)
Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Sungwon Adcock Pharmaceutical Co., Ltd.

MFDS item code 201403492 · Approved 2014.07.29 · Insurance code 664901050
Treatment of dyslipidemia; inhibition of the progression of atherosclerosis; prevention of cardiovascular disease
This medication is used as an adjunct to diet for the treatment of primary hypercholesterolemia and mixed dyslipidemia. It helps in the treatment of patients with homozygous familial hypercholesterolemia, and lowers total cholesterol and LDL cholesterol levels in patients with hypercholesterolemia, delaying the progression of atherosclerosis. It is also recommended for children aged 10 to 17 years with familial hypercholesterolemia and is effective as an adjunct to diet for patients with primary dysbetalipoproteinemia. Notably, it helps reduce the risk of stroke, myocardial infarction, and arterial revascularization in older patients at high risk for cardiovascular diseases. Overall, this drug is used to improve blood lipid levels and protect cardiovascular health.
1. Primary hypercholesterolemia (type IIa, including heterozygous familial hypercholesterolemia), mixed dyslipidemia (type IIb), primary dysbetalipoproteinemia (type III), and homozygous familial hypercholesterolemia Patients should follow a standard cholesterol-lowering diet before and during treatment with this drug, and should continue it throughout the treatment period. This drug may be taken at any time of day, with or without food. The initial dose is 5 milligrams once daily. If a greater reduction in LDL cholesterol is needed, the dose may be adjusted as a maintenance dose. The maintenance dose is 10 milligrams once daily, which is adequate for most patients. The maintenance dose should be adjusted as appropriate at intervals of 4 weeks or longer, according to LDL cholesterol levels, the treatment goal, and the patient's response; the dose may be increased up to a maximum of 20 milligrams daily. 3. Elderly patients: Dose adjustment is not required. 4. Patients with renal impairment: No dose adjustment is required in patients with mild or moderate renal impairment. Do not administer to patients with severe renal impairment. Use particular caution when administering 20 mg of this drug to patients with moderate renal impairment. 5. Patients with hepatic impairment: No increase in systemic exposure to rosuvastatin was observed in patients with a Child-Pugh score of 7 or less, whereas an increase was observed in patients with a Child-Pugh score of 8 or 9. Renal function tests should be considered in these patients. There is no experience with administration to patients with a Child-Pugh score greater than 9. Do not administer this drug to patients with active liver disease. 6. Race: Because systemic exposure to this drug is increased in Asian patients, the recommended initial dose is 5 milligrams. Administration of the 40-milligram dose is contraindicated. 7. Patients predisposed to myopathy: The recommended initial dose for patients predisposed to myopathy is 5 milligrams. Administration of the 40-milligram dose is contraindicated in some of these patients.
Ages 10 to 17 years: The usual dosage range is 5 milligrams to 20 milligrams once daily. (There are no clinical data on administration of doses higher than 20 milligrams in pediatric patients.) The dose should be adjusted individually according to the recommended treatment goal for each patient. The dose should be adjusted at intervals of 4 weeks or longer. Safety and efficacy have not been established in children under 10 years of age.
This medication should not be used in certain patients. For example, it can be risky for patients who are allergic to this medication, have severely impaired liver function, have muscle diseases, have severely impaired kidney function, are pregnant or nursing women, and those taking specific medications. It is important to regularly monitor liver function and muscle condition while using this medication. Special caution is required for those with a history of liver disease or heavy alcohol consumption. If symptoms of muscle pain or weakness occur, the patient should inform a healthcare professional immediately and discontinue the medication if necessary. While muscle-related side effects are rare, they can be serious, so careful observation is required. This drug contains lactose, so patients with lactose intolerance should avoid it. When used in combination with other medications, the blood levels of this drug may increase, leading to a higher risk of muscle-related side effects; therefore, patients should discuss their current medications with their healthcare provider. Women who may become pregnant should use appropriate contraceptive methods and should not use this drug during pregnancy. If a pregnancy occurs, the drug should be discontinued immediately. There is no specific antidote for overdose, so management should involve symptomatic treatment and liver function and muscle enzyme testing. Caution is needed while driving or operating machinery, as dizziness and other symptoms may occur. This medication can rarely cause serious skin reactions, liver damage, or kidney problems in some patients, so any unusual symptoms should be reported to a healthcare professional promptly.
Hypersensitivity reactions including angioedema, diabetes, headache, dizziness, constipation, nausea, abdominal pain, pancreatitis, pruritus, rash, urticaria, myalgia, myopathy, rhabdomyolysis, weakness, polyneuropathy, amnesia, peripheral neuropathy, myasthenia gravis, cough, difficulty breathing, diarrhea, ocular myasthenia, thrombocytopenia, jaundice, hepatitis, increased transaminases, Stevens-Johnson syndrome, drug reaction with eosinophilia and systemic symptoms syndrome, drug-induced eczematous rash, lupus-like syndrome, muscle rupture, arthralgia, immune-mediated necrotizing myopathy, hematuria, edema, depression, sleep disorders, interstitial lung disease, sexual dysfunction, gynecomastia, fatal and non-fatal liver failure, cognitive impairment, increased ALT, chest pain, muscle cramps, gout, erectile dysfunction, numbness, sensory disturbances, chest discomfort, loss of appetite, abdominal distention, syncope, generalized pain, fatigue
Not everyone experiences these, and they can vary from person to person.
Store this medication in a tightly closed container to protect it from air and moisture. It is advisable to maintain a storage temperature between 1 to 30 degrees Celsius. This helps to preserve the efficacy of the medication.
Pink round film-coated tablet
30 tablets (10 tablets/PTP x 3)
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowRosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Sungwon Adcock Pharmaceutical Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 5.2mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Chong Kun Dang Pharmaceutical Corp.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Dong Gu Bio Pharmaceutical Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Boryung Pharmaceutical Co., Ltd.

Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication
Jongkundang Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.